Startups
2002
ONE WAY LIVER SL (OWL) (Previously ONE WAY LIVER GENOMICS SL)Metabolomics with pioneering diagnostics products and unique R&D services for the scientific community
Address
Parque Tecnológico de Bizkaia EDIFICIO 502, 48160 Derio, Spain
Finance Data
| Date | Investors | Amount | Stage | |
| Jan 2004 | 1 € | Early VC |
Financial Overview
No revenue recorded yet
CERCA ownership
Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Company Description
The activity of the company is centered in the area of health and its objective is to identify, validate, patent and commercialize early diagnostic and/or prognostic systems, as well as therapeutic targets of hepatic diseases and other great prevalence complex pathologies. To accomplish this we use, metabolomics and bioinformatics have established a complete and highly productive platform which supports the advance of our developments.
Business Lines
Metabolomics Services to external organizations: OWL offers metabolomic services to pharmaceutical and biotechnology companies in key areas such as biomarker discovery, clinical studies, companion diagnostics and toxicology.
Business Lines
Metabolomics Services to external organizations: OWL offers metabolomic services to pharmaceutical and biotechnology companies in key areas such as biomarker discovery, clinical studies, companion diagnostics and toxicology.
Product description
OWL´s two business lines stem from our in depth knowledge of metabolomics and liver diseases.
DIAGNOSTIC PRODUCTS:
"OWLiver Test" is the first "in vitro" test for determining steatosis and NASH.
The company also develops diagnostic markers research for high prevalence diseases.
R&D SERVICES:
OWL applies its expertise in metabolomics and lipidomics to provide services to the pharmaceutical, food and cosmetics industries, as well as research centers, biotech companies and CROs.
DIAGNOSTIC PRODUCTS:
"OWLiver Test" is the first "in vitro" test for determining steatosis and NASH.
The company also develops diagnostic markers research for high prevalence diseases.
R&D SERVICES:
OWL applies its expertise in metabolomics and lipidomics to provide services to the pharmaceutical, food and cosmetics industries, as well as research centers, biotech companies and CROs.
Company Closed or Exit Year